Citations (95)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (8)
E. Lindholm, B. Berglund, J. Kewhnter & E. Haglind. (1997) Worry Associated with Screening for Colorectal Carcinomas. Scandinavian Journal of Gastroenterology 32:3, pages 238-245.
Read now
Read now
J. Kewenter, H. Brevinge, B. Engarás, E. Haglind & C. Ährén. (1994) Results of Screening, Rescreening, and Follow-up in a Prospective Randomized Study for Detection of Colorectal Cancer by Fecal Occult Blood Testing: Results for 68,308 Subjects. Scandinavian Journal of Gastroenterology 29:5, pages 468-473.
Read now
Read now
J. Jensen, J. Kewenter & J. Swedenborg. (1993) The Correlation of Symptoms, Occult Blood Tests, and Neoplasms in Patients Referred for Double-Contrast Barium Enema. Scandinavian Journal of Gastroenterology 28:10, pages 911-914.
Read now
Read now
O. D. Jørgensen, O. Kronborg & C. Fenger. (1993) The Funen Adenoma Follow-Up Study Characteristics of Patients and Initial Adenomas in Relation to Severe Dysplasia. Scandinavian Journal of Gastroenterology 28:3, pages 239-243.
Read now
Read now
B. Møller Jensen, O. Kronborg & C. Fenger. (1992) Interval Cancers in Screening with Fecal Occult Blood Test for Colorectal Cancer. Scandinavian Journal of Gastroenterology 27:9, pages 779-782.
Read now
Read now
O. Kronborg, C. Fenger, J. Worm, S. A. Pedersen, J. Hem, K. Bertelsen & J. Qlsen. (1992) Causes of Death during the First 5 Years of a Randomized Trial of Mass Screening for Colorectal Cancer with Fecal Occult Blood Test. Scandinavian Journal of Gastroenterology 27:1, pages 47-52.
Read now
Read now
Ole Kronborg. (1991) Population Screening for Colorectal Cancer, the Goals and Means. Annals of Medicine 23:4, pages 373-379.
Read now
Read now
A. R. Walker, D. K. Whynes & J. D. Hardcastle. (1991) Rehydration of Guaiac-Based Faecal Occult Blood Tests in Mass Screening for Colorectal Cancer: An Economic Perspective. Scandinavian Journal of Gastroenterology 26:2, pages 215-218.
Read now
Read now
Articles from other publishers (87)
Jie-Bin Lew, Marjolein J. E. Greuter, Michael Caruana, Emily He, Joachim Worthington, D. James St John, Finlay A. Macrae, Eleonora Feletto, Veerle M. H. Coupé & Karen Canfell. (2020) Validation of Microsimulation Models against Alternative Model Predictions and Long-Term Colorectal Cancer Incidence and Mortality Outcomes of Randomized Controlled Trials. Medical Decision Making 40:6, pages 815-829.
Crossref
Crossref
Alex van der Steen, Joost van Rosmalen, Sonja Kroep, Frank van Hees, Ewout W. Steyerberg, Harry J. de Koning, Marjolein van Ballegooijen & Iris Lansdorp-Vogelaar. (2016) Calibrating Parameters for Microsimulation Disease Models. Medical Decision Making 36:5, pages 652-665.
Crossref
Crossref
Joris Giai, Catherine Exbrayat, Bastien Boussat, Florence Poncet, Patrice Bureau du Colombier, Marc Colonna & Arnaud Seigneurin. (2014) Sensitivity of a colorectal cancer screening program based on a guaiac test: A population-based study. Clinics and Research in Hepatology and Gastroenterology 38:1, pages 106-111.
Crossref
Crossref
Stephen R. Cole, Tess Gregory, Alex Whibley, Paul Ward, Deborah Turnbull, Carlene Wilson, Ingrid Flight, Adrian Esterman & Graeme P. Young. (2012) Predictors of Re-participation in Faecal Occult Blood Test-Based Screening for Colorectal Cancer. Asian Pacific Journal of Cancer Prevention 13:12, pages 5989-5994.
Crossref
Crossref
Tomasz Kozłowski, Dariusz Godlewski, Maciej Biczysko, Marcin Grochowalski, Marcin Nelke, Jacek Paszkowski, Maciej Borejsza-Wysocki, Łukasz Krokowicz, Piotr Krokowicz, Tomasz Banasiewicz & Michał Drews. (2011) Analysis of the Efficacy of Screening Tests in Colorectal Cancer by Faecal Occult Blood Test - Own Experience. Polish Journal of Surgery 83:8.
Crossref
Crossref
Philip C. Prorok & Pamela M. Marcus. (2010) Cancer Screening Trials: Nuts and Bolts. Seminars in Oncology 37:3, pages 216-223.
Crossref
Crossref
Takuji Ozaki, Akira Tokunaga, Naoto Chihara, Masanori Yoshino, Hideki Bou, Masao Ogata, Masanori Watanabe, Hideyuki Suzuki & Eiji Uchida. (2010) Total Colonoscopy Detects Early Colorectal Cancer More Frequently than Advanced Colorectal Cancer in Patients with Fecal Occult Blood. Journal of Nippon Medical School 77:4, pages 195-203.
Crossref
Crossref
Margot A. Gosney. 2010. Brocklehurst's Textbook of Geriatric Medicine and Gerontology. Brocklehurst's Textbook of Geriatric Medicine and Gerontology
791
800
.
Kimberly W. Sanford & Richard A. McPherson. (2009) Fecal Occult Blood Testing. Clinics in Laboratory Medicine 29:3, pages 523-541.
Crossref
Crossref
Leo G. van Rossum, Anne F. van Rijn, Robert J. Laheij, Martijn G. van Oijen, Paul Fockens, Han H. van Krieken, Andre L. Verbeek, Jan B. Jansen & Evelien Dekker. (2008) Random Comparison of Guaiac and Immunochemical Fecal Occult Blood Tests for Colorectal Cancer in a Screening Population. Gastroenterology 135:1, pages 82-90.
Crossref
Crossref
E. I. Michailova. (2007) A GUAIAC PROBE AND AN IMMUNE MARKER TEST FOR HIDDEN BLOOD IN FAECES IN AN UNINVASIVE CANCER DIAGNOSTIC OF A GASTROINTESTINAL TRACT. Health and Ecology Issues:3, pages 128-134.
Crossref
Crossref
Paul Hewitson, Paul P Glasziou, Les Irwig, Bernie Towler & Eila Watson. (2007) Screening for colorectal cancer using the faecal occult blood test, Hemoccult. Cochrane Database of Systematic Reviews 2011:2.
Crossref
Crossref
Michael V. Maciosek, Leif I. Solberg, Ashley B. Coffield, Nichol M. Edwards & Michael J. Goodman. (2006) Colorectal Cancer Screening. American Journal of Preventive Medicine 31:1, pages 80-89.
Crossref
Crossref
I. Sobhani & M. Abolhassani. 2006. Le dépistage du cancer colorectal. Le dépistage du cancer colorectal
43
55
.
A. G. Zauber, I. Vogelaar, M. Van Ballegooijen, R. Boer, F. Loeve, J. D. F. Habbema & S. J. Winawer. 2006. Highlights in Gastrointestinal Oncology. Highlights in Gastrointestinal Oncology
111
128
.
W M Thomas, G Pye, J D Hardcastle & A R Walker. (1992) Screening for colorectal carcinoma: An analysis of the sensitivity of Haemoccult. British Journal of Surgery 79:8, pages 833-835.
Crossref
Crossref
J Kewenter, B Engarås, E Haglind & J Jensen. (1990) Value of retesting subjects with a positive Hemoccult® in screening for colorectal cancer. British Journal of Surgery 77:12, pages 1349-1351.
Crossref
Crossref
S Bülow, L B Svendsen & A Mellemgaard. (1990) Metachronous colorectal carcinoma. British Journal of Surgery 77:5, pages 502-505.
Crossref
Crossref
Ismail Jatoi & William F. Anderson. (2005) Cancer Screening. Current Problems in Surgery 42:9, pages 620-682.
Crossref
Crossref
Franka Loeve, Rob Boer, Ann G. Zauber, Marjolein van Ballegooijen, Gerrit J. van Oortmarssen, Sidney J. Winawer & J. Dik F. Habbema. (2004) National Polyp Study data: Evidence for regression of adenomas. International Journal of Cancer 111:4, pages 633-639.
Crossref
Crossref
Ronald E Myers, Barbara Turner, David Weinberg, Terry Hyslop, Walter W Hauck, Timothy Brigham, Todd Rothermel, James Grana & Neil Schlackman. (2004) Impact of a physician-oriented intervention on follow-up in colorectal cancer screening. Preventive Medicine 38:4, pages 375-381.
Crossref
Crossref
Toru Nagao & Saman Warnakulasuriya. (2003) Annual screening for oral cancer detection. Cancer Detection and Prevention 27:5, pages 333-337.
Crossref
Crossref
David S. Alberts. (2002) Reducing the Risk of Colorectal Cancer by Intervening in the Process of Carcinogenesis. The Cancer Journal 8:3, pages 208-221.
Crossref
Crossref
Christophe Rosty & Michael Goggins. (2002) Early detection of pancreatic carcinoma. Hematology/Oncology Clinics of North America 16:1, pages 37-52.
Crossref
Crossref
Ronald E. Myers, Barbara Turner, David Weinberg, Walter W. Hauck, Terry Hyslop, Timothy Brigham, Todd Rothermel, James Grana & Neil Schlackman. (2001) Complete Diagnostic Evaluation in Colorectal Cancer Screening: Research Design and Baseline Findings. Preventive Medicine 33:4, pages 249-260.
Crossref
Crossref
Philip C. Prorok, Gerald L. Andriole, Robert S. Bresalier, Saundra S. Buys, David Chia, E. David Crawford, Ronald Fogel, Edward P. Gelmann, Fred Gilbert, Marsha A. Hasson, Richard B. Hayes, Christine Cole Johnson, Jack S. Mandel, Albert Oberman, Barbara O'Brien, Martin M. Oken, Sameer Rafla, Douglas Reding, Wilmer Rutt, Joel L. Weissfeld, Lance Yokochi & John K. Gohagan. (2000) Design of the prostate, lung, colorectal and ovarian (PLCO) cancer screening trial. Controlled Clinical Trials 21:6, pages 273S-309S.
Crossref
Crossref
Ralph H. Hruban, Robb E. Wilentz & Scott E. Kern. (2000) Genetic Progression in the Pancreatic Ducts. The American Journal of Pathology 156:6, pages 1821-1825.
Crossref
Crossref
L. Ferrucci, E. Benvenuti, B. Bartali, S. Bandinelli, A. Iorio, C. R. Russo & F. Lauretani. (2014) Preventive health care for older women: Life-style recommendations and new directions. Aging Clinical and Experimental Research 12:2, pages 113-131.
Crossref
Crossref
Gary R. Zuckerman, Chandra Prakash, Matthew P. Askin & Blair S. Lewis. (2000) AGA technical review on the evaluation and management of occult and obscure gastrointestinal bleeding. Gastroenterology 118:1, pages 201-221.
Crossref
Crossref
V Bouvier, G Launoy, C Herbert, H Lefevre, J Maurel & M Gignoux. (1999) Colorectal cancer after a negative Haemoccult II® test and programme sensitivity after a first round of screening: The experience of the Department of Calvados (France). British Journal of Cancer 81:2, pages 305-309.
Crossref
Crossref
Barbara C. Tilley, Sally W. Vernon, Ronald Myers, Karen Glanz, Mei Lu, Kathryn Hirst & Alan R. Kristal. (1999) The Next Step Trial: Impact of a Worksite Colorectal Cancer Screening Promotion Program. Preventive Medicine 28:3, pages 276-283.
Crossref
Crossref
Cynthia Evans. 1999. Menopause. Menopause
245
262
.
R.Y Declan Fleming. (1998) Colorectal cancer screening and follow-up. Surgical Oncology 7:3-4, pages 125-137.
Crossref
Crossref
BP Towler, L Irwig, P Glasziou, D Weller & J Kewenter. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
S. W. Vernon. (1997) Participation in Colorectal Cancer Screening: A Review. JNCI Journal of the National Cancer Institute 89:19, pages 1406-1422.
Crossref
Crossref
Margaret A Harris & Julie E Byles. (2016) A Survey of Screening Compliance among First Degree Relatives of People with Colon Cancer in New South Wales. Journal of Medical Screening 4:1, pages 29-34.
Crossref
Crossref
David A. Ahlquist. (1997) FECAL OCCULT BLOOD TESTING FOR COLORECTAL CANCER. Gastroenterology Clinics of North America 26:1, pages 41-55.
Crossref
Crossref
Ole Kronborg, Claus Fenger, Jørn Olsen, Ole Dan Jørgensen & Ole Søndergaard. (1996) Randomised study of screening for colorectal cancer with faecal-occult-blood test. The Lancet 348:9040, pages 1467-1471.
Crossref
Crossref
Jack D Hardcastle, Jocelyn O Chamberlain, Michael HE Robinson, Susan M Moss, Satya S Amar, Tom W Balfour, Peter D James & Christine M Mangham. (1996) Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. The Lancet 348:9040, pages 1472-1477.
Crossref
Crossref
Haruhiko Shida, Kanako Ban, Masao Matsumoto, Kozo Masuda, Tomohiro Imanari, Takehisa Machida, Takashi Yamamoto & Tohru Inoue. (1996) Asymptomatic colorectal cancer detected by screening. Diseases of the Colon & Rectum 39:10, pages 1130-1135.
Crossref
Crossref
Finlay A Macrae. (1996) Screening for colorectal cancer, 1996. Medical Journal of Australia 165:2, pages 102-105.
Crossref
Crossref
Donald F. Lum & Mark Lane Welton. (1996) Benign Colorectal Polyps: Endoscopic Surveillance Guidelines and Effects on Colorectal Cancer Risk. Surgical Oncology Clinics of North America 5:3, pages 621-632.
Crossref
Crossref
Jan Kewenter & Hans Brevinge. (1996) Endoscopic and surgical complications of work-up in screening for colorectal cancer. Diseases of the Colon & Rectum 39:6, pages 676-680.
Crossref
Crossref
Glenn Salkeld, Graeme Young, Les Irwig, Marion Haas & Paul Glasziou. (1996) Cost‐effectiveness analysis of screening by faecal occult blood testing for colorectal cancer in Australia. Australian and New Zealand Journal of Public Health 20:2, pages 138-143.
Crossref
Crossref
Bernard Levin. (2017) Screening for Colorectal Cancer. Cancer Control 3:1, pages 20-25.
Crossref
Crossref
Jeanne M. Ferrante. (1996) COLORECTAL CANCER SCREENING. Medical Clinics of North America 80:1, pages 27-43.
Crossref
Crossref
Gabriel A. KuneGabriel A. Kune. 1996. Causes and Control of Colorectal Cancer. Causes and Control of Colorectal Cancer
287
334
.
Jack S. Mandel. 1996. Advances in Cancer Screening. Advances in Cancer Screening
51
76
.
Jocelyn Chamberlain. 1996. Evaluation of Cancer Screening. Evaluation of Cancer Screening
55
75
.
Gabriel A Kune & Luis Vitetta. (2022) The Causes of Ordinary Colorectal Adenomas: The Key to the Control of Colorectal Cancer?. Journal of the Royal Society of Medicine 88:11, pages 625-628.
Crossref
Crossref
SALLY W. VERNON. (1995) Adherence to Colorectal Cancer Screening. Annals of the New York Academy of Sciences 768:1, pages 292-295.
Crossref
Crossref
Aileen R Neilson & David K Whynes. (1995) Determinants of persistent compliance with screening for colorectal cancer. Social Science & Medicine 41:3, pages 365-374.
Crossref
Crossref
DeAnn Lazovich, Noel S Weiss, Nancy G Stevens, Emily White, Barbara McKnight & Edward H Wagner. (2016) A Case-Control Study to Evaluate Efficacy-Of Screening for Faecal Occult Blood. Journal of Medical Screening 2:2, pages 84-89.
Crossref
Crossref
B. CROTTY & D. J. R. ST JOHN. (2008) Early detection, screening and surveillance for colorectal cancer. Australian and New Zealand Journal of Medicine 25:3, pages 236-238.
Crossref
Crossref
Bernie Towler, Les Irwig, Paul Glasziou, Marion Haas, Angela Plunkett & Glenn Salkeld. (2010) The potential benefits and harms of screening for colorectal cancer. Australian Journal of Public Health 19:1, pages 24-28.
Crossref
Crossref
David P. Weller, Neville Owen, Janet E. Hiller, Kristyn Willson & David Wilson. (2010) Colorectal cancer and its prevention: prevalence of beliefs, attitudes, intentions and behaviour. Australian Journal of Public Health 19:1, pages 19-23.
Crossref
Crossref
David Weller, John Moss, Janet Hiller, David Thomas & John Edwards. (2009) Screening for Colorectal Cancer: What are the Costs?. International Journal of Technology Assessment in Health Care 11:1, pages 26-39.
Crossref
Crossref
Hidenori Nakama. (2016) A Comparative Study on the Efficacy of a Mass Screening Program for Colorectal Cancer — Comparison Between Cancer Cases Detected by Mass Screening and by Outpatient Clinics. Asia Pacific Journal of Public Health 7:3, pages 159-164.
Crossref
Crossref
D. H. Bennett & J. D. Hardcastle. (1994) Screening for colorectal cancer.. Postgraduate Medical Journal 70:825, pages 469-474.
Crossref
Crossref
David Weller, David Thomas, Janet Hiller, Alistair Woodward & John Edwards. (2008) SCREENING FOR COLORECTAL CANCER USING AN IMMUNOCHEMICAL TEST FOR FAECAL OCCULT BLOOD: RESULTS OF THE FIRST 2 YEARS OF A SOUTH AUSTRALIAN PROGRAMME. Australian and New Zealand Journal of Surgery 64:7, pages 464-469.
Crossref
Crossref
D. K. Whynes, A. R. Neilson, M. H. E. Robinson & J. D. Hardcastle. (1994) Colorectal cancer screening and quality of life. Quality of Life Research 3:3, pages 191-198.
Crossref
Crossref
David Weller, Janet Hiller, Alistair Woodward & Justin Beilby. (1994) Screening for colorectal cancer: Knowledge, attitudes and practices of South Australian GPs. Medical Journal of Australia 160:10, pages 620-624.
Crossref
Crossref
James St John. (1994) Screening for colorectal cancer: “On your marks…”. Medical Journal of Australia 160:10, pages 596-597.
Crossref
Crossref
D. C. Wherry & W. M. Thomas. (1994) The yield of flexible fiberoptic sigmoidoscopy in the detection of asymptomatic colorectal neoplasia. Surgical Endoscopy 8:5, pages 393-395.
Crossref
Crossref
J. Olsen, J. Lynggaard, O. Kronborg & M. Ewertz. (1994) Dietary risk factors for cancer and adenomas of the large intestine. A case-control study within a screening trial in Denmark. European Journal of Cancer 30:1, pages 53-60.
Crossref
Crossref
H. Nakama. (1994) A study on the efficacy of a screening program for colorectal cancer in a small Japanese village. Journal of Molecular Medicine 72:2, pages 117-121.
Crossref
Crossref
D. James B. St. John, Graeme P. Young, Masha A. Alexeyeff, Melissa C. Deacon, Alan M. Cuthbertson, Finlay A. Macrae & J.Campbell B. Penfold. (1993) Evaluation of new occult blood tests for detection of colorectal neoplasia. Gastroenterology 104:6, pages 1661-1668.
Crossref
Crossref
Jack S. Mandel, John H. Bond, Timothy R. Church, Dale C. Snover, G. Mary Bradley, Leonard M. Schuman & Fred Ederer. (1993) Reducing Mortality from Colorectal Cancer by Screening for Fecal Occult Blood. New England Journal of Medicine 328:19, pages 1365-1371.
Crossref
Crossref
Michael J. Solomon & Robin S. McLeod. (1993) Clinical assessment of biomedical technology. Diseases of the Colon & Rectum 36:3, pages 301-307.
Crossref
Crossref
C. Johansen, A. Mellemgaard, T. Skov, J. Kj�rgaard & E. Lynge. (1993) Colorectal cancer in Denmark 1943?1988. International Journal of Colorectal Disease 8:1, pages 42-47.
Crossref
Crossref
Michael J. Solomon & Robin S. McLeod. (1993) Screening Strategies for Colorectal Cancer. Surgical Clinics of North America 73:1, pages 31-45.
Crossref
Crossref
D. James B. St. John, Graeme P. Young, John G. McHutchison, Melissa C. Deacon & Masha A. Alexeyeff. (1992) Comparison of the Specificity and Sensitivity of Hemoccult and HemoQuant in Screening for Colorectal Neoplasia. Annals of Internal Medicine 117:5, pages 376-382.
Crossref
Crossref
Patrick Arveux, Gérard Durand, Chantal Milan, Laurent Bedenne, Danièle Lévy, Bui Dang Ha Doan & Jean Faivre. (1992) Views of a general population on mass screening for colorectal cancer: The burgundy study. Preventive Medicine 21:5, pages 574-581.
Crossref
Crossref
David A. Ahlquist. (1992) Occult blood screening obstacles to effectiveness. Cancer 70:S3, pages 1259-1265.
Crossref
Crossref
Sam Shapiro. (1992) Goals of screening. Cancer 70:S3, pages 1252-1258.
Crossref
Crossref
David K. Whynes, Andrew R. Walker & Jack D. Hardcastle. (2006) Cost savings in mass population screening for colorectal cancer resulting from the early detection and excision of adenomas. Health Economics 1:1, pages 53-60.
Crossref
Crossref
P. Arveux, C. Milan, G. Durand, L. Bedenne & J. Faivre. (1992) Le dépistage de masse du cancer colorectal en Bourgogne. Acta Endoscopica 22:S1, pages 81-85.
Crossref
Crossref
J. Faivre, O. Grosbost & Ph. Chatrenet. (1992) Epidémiologie du cancer colorectal. Acta Endoscopica 22:S1, pages 75-80.
Crossref
Crossref
D. J. B. ST JOHN. (2008) Screening tests for colorectal neoplasia. Journal of Gastroenterology and Hepatology 6:6, pages 538-544.
Crossref
Crossref
Andrew Walker & David K. Whynes. (1991) Participation and screening programmes for colorectal cancer: More would be better?. Journal of Health Economics 10:2, pages 207-225.
Crossref
Crossref
Guido Castiglione, Grazia Grazzini, Anna Poll, Rita Bonardi & Stefano Ciatto. (2018) Hemoccult Sensitivity Estimate in a Screening Program for Colorectal Cancer in the Province of Florence. Tumori Journal 77:3, pages 243-245.
Crossref
Crossref
Jeffery P. Struewing, Donna M. Pape & Dorothy A. Snow. (1991) Improving Colorectal Cancer Screening in a Medical Residents’ Primary Care Clinic. American Journal of Preventive Medicine 7:2, pages 75-81.
Crossref
Crossref
Karsten Bech, Ole Kronborg & Claus Fenger. (1991) Adenomas and hyperplastic polyps in screening studies. World Journal of Surgery 15:1, pages 7-13.
Crossref
Crossref
Alistair Woodward & David Weller. (1990) Colorectal cancer: implications of mass screening for public health. Medical Journal of Australia 153:2, pages 81-88.
Crossref
Crossref
D. J. B. St John. (2008) WILL COLORECTAL CANCER SCREENING BE TOO COSTLY?. Australian and New Zealand Journal of Surgery 60:6, pages 415-417.
Crossref
Crossref
CHRISTOPHER B. WILLIAMS & LAURENT BEDENNE. (1990) Management of colorectal polyps: Is all the effort worthwhile?. Journal of Gastroenterology and Hepatology 5:S-1, pages 144-165.
Crossref
Crossref
J. Faivre. (1990) Le dèpistage de masse du cancer colorectal: bientôt une réalité?Will screening for colorectal cancer soon become a reality?Despistaje de masa del cancer colorrectal: ¿ Una realidad cercana?. Acta Endoscopica 20:1, pages 1-4.
Crossref
Crossref